» Articles » PMID: 40027643

Precursor RNA Structural Patterns at SF3B1 Mutation Sensitive Cryptic 3' Splice Sites

Overview
Journal bioRxiv
Date 2025 Mar 3
PMID 40027643
Authors
Affiliations
Soon will be listed here.
Abstract

SF3B1 is a core component of the spliceosome involved in branch point recognition and 3' splice site selection. SF3B1 mutation is common in myelodysplastic syndrome and other blood disorders. The most common mutation in SF3B1 is K700E, a lysine to glutamic acid change within the pre-mRNA interacting heat repeat domain. A hallmark of SF3B1 mutation is an increased use of cryptic 3' splice sites; however, the properties distinguishing SF3B1-sensitive splice junctions from other alternatively spliced junctions are unknown. We identify a subset of 192 core splice junctions that are mis-spliced with SF3B1 K700E mutation. We use our core set to test whether SF3B1-sensitive splice sites are different from control cryptic 3' splice sites via RNA structural accessibility. As a comparison, we define a set of SF3B1-resistant splice junctions with cryptic splice site use that does not change with SF3B1 K700E mutation. We find sequence differences between SF3B1-sensitive and SF3B1-resistant junctions, particularly at the cryptic sites. SF3B1-sensitive cryptic 3' splice sites are within an extended polypyrimidine tract and have lower splice site strength scores. We develop experimental RNA structure data for 83 SF3B1-sensitive junctions and 39 SF3B1-resistant junctions. We find that the pattern of structural accessibility at the NAG splicing motif in cryptic and canonical 3' splice sites is similar. In addition, this pattern can be found in both SF3B1-resistant and SF3B1-sensitive junctions. However, SF3B1-sensitive junctions have cryptic splice sites that are less structurally distinct from the canonical splice sites. In addition, SF3B1-sensitive splice junctions are overall more flexible than SF3B1-resistant junctions. Our results suggest that the SF3B1-sensitive splice junctions have unique structure and sequence properties, containing poorly differentiated, weak splice sites that lead to altered 3' splice site recognition in the presence of SF3B1 mutation.

References
1.
Golomb L, Bublik D, Wilder S, Nevo R, Kiss V, Grabusic K . Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis. Mol Cell. 2012; 45(2):222-32. PMC: 3270374. DOI: 10.1016/j.molcel.2011.11.022. View

2.
Siegfried N, Busan S, Rice G, Nelson J, Weeks K . RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP). Nat Methods. 2014; 11(9):959-65. PMC: 4259394. DOI: 10.1038/nmeth.3029. View

3.
Zhao B, Hu X, Zhou Y, Shi Y, Qian R, Wan Y . Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation. Biochem Biophys Res Commun. 2021; 546:21-28. DOI: 10.1016/j.bbrc.2021.01.084. View

4.
Darman R, Seiler M, Agrawal A, Lim K, Peng S, Aird D . Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point. Cell Rep. 2015; 13(5):1033-45. DOI: 10.1016/j.celrep.2015.09.053. View

5.
Kumar J, Lackey L, Waldern J, Dey A, Mustoe A, Weeks K . Quantitative prediction of variant effects on alternative splicing in using endogenous pre-messenger RNA structure probing. Elife. 2022; 11. PMC: 9236610. DOI: 10.7554/eLife.73888. View